Evidence map›Paper›PMID 42903349›Full record

ArticleFrontiers in public health2026

Cluster investigation report: a probable urine-associated transmission event of severe fever with thrombocytopenia syndrome-a case report.

Yan Su, An Chengcheng, Chen Qiongli, Li Zhiyuan, Li Shuwen, Pan Jingjing, Li Yi, Wang Haifeng, Huang Xueyong, Ye Ying

Abstract readCase Reports
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yan SuInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
An ChengchengInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Chen QiongliInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Li ZhiyuanInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Li ShuwenInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Pan JingjingInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Li YiInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Wang HaifengInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Huang XueyongInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.
Ye YingInstitute for Communicable Disease Control and Prevention, Henan Center for Disease Control and Prevention, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne viral disease with a high case fatality rate. Human-to-human transmission has been increasingly documented, primarily through direct contact with blood or bloody secretions. On June 21, 2025, a case of SFTS was reported in Zhumadian City, Henan Province. On July 3, a second case-epidemiologically linked to the first-was reported to the local Centers for Disease Control (CDC) through the notifiable disease reporting system, following laboratory confirmation on July 1. Case presentation: A 77-year-old female farmer with underlying comorbidities was hospitalized with fever, leukopenia, and thrombocytopenia, and subsequently died of SFTS. Her 31-year-old granddaughter, who had an open wound on her hand, cared for the patient and cleaned her urine. Eleven days later, she developed fever, nausea, vomiting, headache, fatigue, and myalgia. Laboratory tests confirmed SFTS virus infection by RT-PCR, with an initial cycle threshold (Ct) value of 38.85, which subsequently decreased to 31.48 over the following 2 days, indicating active viral replication. She recovered after antiviral therapy and was discharged on July 7. Comprehensive epidemiological investigation ruled out other potential transmission routes, including blood contact, tick bites, and environmental exposure. However, direct virological evidence from the index patient's urine and genomic sequencing to confirm viral homology between the two cases were not available. Conclusion: This report describes a probable human-to-human SFTS transmission event associated with urine exposure through an open wound. While the absence of direct virological and genomic evidence precludes definitive confirmation, the convergence of epidemiological, clinical, and temporal evidence strongly supports this transmission route. This case highlights the need for enhanced protective measures-particularly the use of gloves when handling any body fluids, including urine-during care of SFTS patients.

Indexed as

Severe Fever with Thrombocytopenia SyndromeAdultAgedChinaCluster AnalysisFatal OutcomeFemaleHumansPhleboviruscase reportcluster eventhuman-to-human transmissionpublic health interventionssevere fever with thrombocytopenia syndromeurine-associated transmission

Identifiers

PMID42903349
PMCPMC13680459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.